Frontiers in oncology.

Submissions that are surgical in nature are not in scope for this section and should be submitted to the Surgical Oncology Section of Frontiers in Oncology. Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and …Frontiers in Oncology ... Consult your physician. Privacy Notice | Terms and Conditions of Use ©2019 PROBIOMED S.A. de C.V. | Consult your physician.Dongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.Perhaps key for incorporation of TDM in oncology, are barriers aligned with knowledge . As evidence to support TDM in oncology is largely provided by academic initiatives, the body of literature is affected by factors such as limited funding and time, and may be the reason for a paucity of clinical studies.Sep 8, 2022 ... Welcome to this conference regarding cancer research and therapy organized by the Department of Oncology-Pathology.

The International Cardio-Oncology Society registry shows 21 countries with national cardio-oncology programs, and 81% of centers are in upper-middle to high-income countries . A study of oncologists in the central US showed 67.5% practiced in exclusively urban locations, 11.3% in exclusively rural locations, and 21.1% in both rural and urban …

Frontier Communications is a well-known provider of internet, phone, and television services. If you’re in the market for a new TV package, you might be wondering what options Fron...Our ultimate goal is to provide a mechanism of communication between clinicians and researchers that will stimulate and promote a continuation of the multimodal strategies characteristic of the genitourinary oncology field. This section welcomes contributions related to both clinical and basic research findings in the various genitourinary ...

A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients.francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.Jul 4, 2022 · 1 Cancer Research Center for Health Equity, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 2 Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA, United States brian d adams. Brain Institute of America. New Haven, United States. Associate Editor. Cancer Molecular Targets and Therapeutics.

Trouble of the curve

Frontiers in Oncology ... Consult your physician. Privacy Notice | Terms and Conditions of Use ©2019 PROBIOMED S.A. de C.V. | Consult your physician.

Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ). Table 1: Frontiers' APCs are structured in four categories, depending on the journal's maturity and the level of research funding and/or open access funding available in various research communities. They also support article types with lower prices or articles that are free of charge. Frontiers' APCs are charged in US$. 1 Hookipa Pharma Inc., New York, NY, United States; 2 Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland; Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell responses. Arenaviruses have been widely studied …markus brunner. Medical University of Vienna. Vienna, Austria. Associate Editor. Head and Neck Cancer. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Background aims: The field of cell and gene therapy in oncology has moved rapidly since 2017 when the first cell and gene therapies, Kymriah followed by Yescarta, were …Sep 5, 2022 ... We're addressing the challenge of immune evasion from two angles. Firstly, by finding novel ways to overcome the defensive mechanisms that ...The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...

The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and ...Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, …2.1 Characterization of Resistance in Cancer. Drug resistance in cancer is an intimate occurrence that results when cancer becomes tolerant of pharmaceutical treatment ().An extensive range of factors contributes to the development of resistance against anticancer drugs, including genetic mutations, altered epigenetics, enhanced drug efflux, …Survival of 48866 cancer patients: results from Nantong area, China. Objective: This study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China. Methods: Patients with cancer registered between 2007 and 2017 in the Nantong rural …Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.

This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.

Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn;Frontiers in Oncology ... Consult your physician. Privacy Notice | Terms and Conditions of Use ©2019 PROBIOMED S.A. de C.V. | Consult your physician.The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ...Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ).Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.

Best loan app

Scope. The field of radiation oncology is currently entering a new frontier of more personalized cancer treatment. We are being led into this new frontier by the explosion of information in cancer biology. From the maturation of 3-dimensional (3-D) to 4- dimensional (4-D) photon and proton radiation planning and delivery, and the refinement of ...

Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology. Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections. Aram Boada. Anna Martinez-Cardús. Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression.Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).Jürgen Schlegel. Ekkehard Hewer. Bianca Pollo. Theoni Maragkou. Frontiers in Oncology. doi 10.3389/fonc.2024.1389608. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ... Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). Reviews should present a complete overview of the state of the art (and should not merely summarize the literature), as well as discuss the following: 1) Different schools of thought or controversies, 2) Fundamental concepts, issues, and problems, 3) Current research gaps, 4) Potential developments in the field.Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression.Jan 9, 2024 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.

Editorial: Novel targets for ovarian cancer stem cells. Although ovarian cancer (OC) has been considered as a chemo-sensitive tumor type, the majority of patients develop chemoresistance, which drives tumor relapse within two years. Cumulative evidence supports that the presence of cancer stem cells (CSCs), in tumor residuals are …3 days ago · Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics. The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...Instagram:https://instagram. free crossword word search Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ... san miguel de allende airport 2 days ago · Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer. fbox movie Our ultimate goal is to provide a mechanism of communication between clinicians and researchers that will stimulate and promote a continuation of the multimodal strategies characteristic of the genitourinary oncology field. This section welcomes contributions related to both clinical and basic research findings in the various genitourinary ... sharon r pine. Division of Medical Oncology, Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus. Aurora, United States. Assistant Field Chief Editor. Frontiers in Oncology. women safety Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer. chicago to new orleans Learn more about Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.If you’re looking for an affordable airline option, Frontier Airlines might be the perfect choice. With their low fares and various routes, it’s no wonder that many travelers choos... nyu psychology Feb 28, 2023 ... In an initial trial, patients who were in remission after previously having cancer were vaccinated, with the goal of preventing recurrence. Now, ...Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more. flights from dc to los angeles bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology.Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. bass store Frontiers in Oncology 影响因子：4.848 Frontiers in Oral Health. P. Frontiers in Pediatrics 影响因子：2.634 Frontiers in Pharmacology 影响因子：4.225 List of posts by tag Frontiers in Oncology usa today and crossword timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new … 102.5 fm atlanta Frontiers in Cancer Science 2023 · Date: 06 November 2023 · Time: 09:00 AM · Venue: National University of Singapore University Cultural Centre 50 Kent Ridge&n... imitation of life lana turner Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.Frontiers in Oncology publishes high-quality research on all aspects of cancer, from basic science to clinical applications. It has a fast and rigorous peer review process, a high impact factor and cite score, and a large network of editors and reviewers.